| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-rat LD50 4000 mg/kg Therapie. Vol. 17, Pg. 1349, 1962.
intraperitoneal-rat LD50 3180 mg/kg Drugs in Japan Vol. 6, Pg. 740, 1982.
oral-mouse LD50 4550 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 3, Pg. 187, 1969.
intraperitoneal-mouse LD50 4050 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 3, Pg. 187, 1969.
intravenous-dog LDLo > 250 mg/kg Therapie. Vol. 17, Pg. 1349, 1962.
|
| Dermal Toxicity: |
subcutaneous-rat LD50 4850 mg/kg Drugs in Japan Vol. 6, Pg. 740, 1982.
subcutaneous-mouse LD50 991 mg/kg Zeitschrift fuer die Gesamte Innere Medizin und Ihre Grenzgebiete. Vol. 2, Pg. 333, 1947.
|
| Inhalation Toxicity: |
|
Not determined
|